Intellipharmaceutics International Inc. (IPCI)

[tilator]

Tilator, I have to totally disagree with you on this one. The worse thing this company ever did was expand the manufacturing capabilities. Generics is tough and tight business to break into. You would need a massive sales force as well as a massive network for distribution. was involved with a company which was breaking into the market with NDA's. on average their sales force and distribution was well over 100 million ! it took 2 full years to just break even.

Sounds just like you do not know what you are writing, because you mix generics and NDA to each other.

Selling NDA drug is exactly what you are describing, because you have to make the market. You are selling something new physicians don't yet know. You have to show how your new treatment is better than the old ones. You have to do this to every single physician.

Selling generics is a totally different ball game. Someone has already made the market. You do not need to tell everyone why it is better in treating patients. You need to be commercially better and it's something very much different. If you have been to this business, you must understand this clearly.

IPCI should start making and selling metformin and levetiracetam right now on their own and expand this as soon as possible. Only a product that does exist, can be sold. Now they just sit back and wait someone to come and buy. This does not work.